Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care reported its highest-ever Q1 revenue, with Net Sales rising 12.31% to Rs. 94.05 Cr from Rs. 83.74 Cr a year ago. Profit Before Tax jumped 77.80% to Rs. 11.29 Cr and Profit After Tax surged 79.87% to Rs. 8.31 Cr, driven by a strong comeback in the Pain Management category, which grew 26% overall. Brand Comfy (Women's Hygiene) grew 11%, Brand Relief (Congestion) rose 34%, while Electro+ (Rehydration) declined 17%. The company is now focusing on increasing household penetration of balms, expanding roll-on category presence, and growing via Ecom and Quick Commerce channels. Management has set a target to lift operating profit (EBIT) margin from 11.44% to 13% through a mix of revenue growth and operational efficiencies.
This is a positive quarter for shareholders — strong profit growth, return to double-digit volume growth in the core pain management business, and a clear margin expansion target. However, the continued decline in the Rehydration/Electro+ segment is a watchpoint. Overall, the presentation reinforces a growth-and-margin improvement narrative that could support positive sentiment in the stock.